Personalized cancer care conference

Journal of Personalized Medicine

Volumn 3, Issue 2, 2013, Pages 70-81

  Zänker, Kurt S ^a,b   Mihich, Enrico ^c   Huber, Hans Peter ^b   Borresen Dale, Anne Lise ^d  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Fritz Bender Foundation   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Allele specific copy number analysis of tumors; Cancer stem cells; Driver genes; Flood of information; Four p medicine; Genome wide association studies; Kateagis; Passenger genes; Personalized individualized medicine; Single nucleotide polymorphism; Supportive and psychological cancer care

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; DOXORUBICIN; PROTEIN P53; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ARTICLE; CANCER CENTER; CANCER FATIGUE; CARCINOGENESIS; CLINICAL TRIAL (TOPIC); ETHICS; GENE EXPRESSION; GENE MUTATION; GENETIC TRAIT; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; METASTASIS; METASTATIC COLORECTAL CANCER; NONHUMAN; ONCOGENE; PERSONALIZED MEDICINE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH; TRIPLE NEGATIVE BREAST CANCER;

EID: 84903712216     PISSN: None     EISSN: 20754426     Source Type: Journal    
DOI: 10.3390/jpm3020070     Document Type: Article

References (21)

1. Hood, L.; Tian, Q. Systems approaches to biology and disease enable translational systems medicine. Genomics Proteomics Bioinformatics 2012, 10, 181-185
2. Ghoussaini, M.; Fletcher, O.; Michalidou, K.; Tumbull, C.; Schmidt, M.K.; Dicks, E.; Dennis, J.; Wang, Q.; Humphrey, M.K.; Luccarini, C. et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet. 2012, 44, 318-321
3. van Loo, P.; Nilsen, G.; Nordgard, S.H.; Volllan, H.K.; Borresen-Dale, A.L.; Kristensen, V.N.; Lingjarde, O.C. Analyzing cancer samples with SNP arrays. Methods Mol. Biol. 2012, 802, 57-72
4. Ganz, P.A.; Earle, C.C.; Goodwin, P.J. Journal of Clinical Oncology update on progress in cancer survivorship care and research. J. Clin. Oncol. 2012, 30, 3655-3666
5. Stratton, M.R. Journeys into the genome of cancer cells. EMBO Mol. Med. 2013, 5, 169-172
6. Hou, Y.; Song, L.; Zhu, P.; Zhang, B.; Tao, Y.; Xu, X.; Lif, F.; Wu, K.; Liang, J.; Shao, D. et al. Single-cell exome sequencing and monoclonal evolution of JAK2-negative myeloproliferative neoplasm. Cell 2012, 148, 873-885
7. Birkbak, N.J.; Wang, Z.C.; Kim, J.Y.; Eklund, A.C.; Li, Q.; Tian, R.; Bowman-Colin, C.; Li, Y.; Greene-Colozzi, A.; Iglehart, J.D. et al. Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. Cancer Discov. 2012, 2, 366-375
8. Caldas, C.; Tannock, I.F. Breast cancer: Tamoxifen-When more might be better. Nat. Rev. Clin. Oncol. 2013, 10, 125-126
9. Mroue, R.; Bissell, M.J. Three-dimensional cultures of mouse mammary epithelial cells. Methods Mol. Biol. 2013, 945, 221-250
10. Vidi, P.A.; Bissell, M.J.; Lelievre, S.A. Three-dimensional culture of human breast epithelial cells: The how and why. Methods Mol. Biol. 2013, 945, 193-219
11. Yi, L.; Lu, C.; Hu, W.; Sun, Y.; Levine, A.J. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation. Cancer Res. 2012, 72, 5635-5645
12. Ellis, M.J.; Ding, L.; Shen, D.; Luo, J., Suman, V.J.; Wallis, J.W.; van Tine, B.A.; Hoog, J.; Goiffon, R.J.; Goldstein, T.C. et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486, 353-360
13. Norton, L.; Massague, J. Is cancer a disease of self-seeding? Nat. Med. 2006, 12, 875-878
14. Comen, E.; Norton, L.; Massague, J. Clinical implication of cancer self-seeding. Nat. Rev. Clin. Oncol. 2011, 8, 369-377
15. Meric-Bernstam, F.; Akcakanat, A.; Chen, H.; Do, K.A.; Sangai, T.; Adkins, F.; Gonzalez-Angulo, A.M.; Rashid, A.; Crosby, K.; Dong, M. et al. PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors. Clin. Cancer Res. 2012, 18, 1777-1789
16. Tian, S.; Simon, I.; Moreno, V.; Reopman, P.; Tabernero, J.; Snel, M.; van't Veer, L.; Salazar, R.; Berards, R.; Capella, G. A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction. Gut 2013, 62, 540-549
17. Curtis, C.; Shah, S.P.; Chin, S.F.; Turashvilli, G.; Rueda, O.M.; Dunning, M.J.; Speed, D.; Lynch, A.G.; Samarajiwa, S.; Yuan, Y. et al. The genomic and transcriptomic architecture of 2,000 breast tumors reveals novel subgroups. Nature 2012, 486, 346-352
18. Derry, J.M.; Mangravite, L.M.; Suver, C.; Furia, M.D.; Henderson, D.; Schildwachter, X.; Bot, B.; Izant, J.; Sieberts, S.K.; Kellen, M.R.; Friend, S.H. Developing predictive molecular maps of human disease through community-based modeling. Nat. Genet. 2012, 44, 127-130
19. Guilmartin, N. The Power of Pause; Jossey-Bass, A Wiley Imprint: San Francisco, CA, USA, 2010
20. Foss, G.S.; Rogne, S. Gene medication or genetic modification? The devil is in the details. Nat. Biotechnol. 2003, 21, 1280-1281
21. Dittmar, T., Zänker, K.S., eds. Role of Cancer Stem Cells in Cancer Biology and Therapy; CRC Press, Taylor & Francis Group: Boca Raton, FL, USA, 2013.